CS240957B2 - Production method of stabile solution containing iron and selenium - Google Patents
Production method of stabile solution containing iron and selenium Download PDFInfo
- Publication number
- CS240957B2 CS240957B2 CS832291A CS229183A CS240957B2 CS 240957 B2 CS240957 B2 CS 240957B2 CS 832291 A CS832291 A CS 832291A CS 229183 A CS229183 A CS 229183A CS 240957 B2 CS240957 B2 CS 240957B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- selenium
- iron
- solution
- sodium selenite
- piglets
- Prior art date
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 72
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 55
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 55
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 5
- 229940065287 selenium compound Drugs 0.000 claims abstract description 11
- 150000003343 selenium compounds Chemical class 0.000 claims abstract description 11
- 229940096010 iron polysaccharide Drugs 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000011573 trace mineral Substances 0.000 claims abstract description 4
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 4
- 229940091258 selenium supplement Drugs 0.000 claims description 53
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 16
- 229960001471 sodium selenite Drugs 0.000 claims description 16
- 239000011781 sodium selenite Substances 0.000 claims description 16
- 235000015921 sodium selenite Nutrition 0.000 claims description 16
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 claims description 6
- 230000007812 deficiency Effects 0.000 claims description 5
- 150000002506 iron compounds Chemical class 0.000 claims description 5
- 239000000376 reactant Substances 0.000 claims description 2
- WALCGGIJOOWJIN-UHFFFAOYSA-N iron(ii) selenide Chemical compound [Se]=[Fe] WALCGGIJOOWJIN-UHFFFAOYSA-N 0.000 abstract description 7
- 239000000243 solution Substances 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229920002307 Dextran Polymers 0.000 description 8
- 102000006587 Glutathione peroxidase Human genes 0.000 description 8
- 108700016172 Glutathione peroxidases Proteins 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 206010039921 Selenium deficiency Diseases 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 206010022971 Iron Deficiencies Diseases 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 244000309465 heifer Species 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003342 selenium Chemical class 0.000 description 1
- 101150101156 slc51a gene Proteins 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI821233A FI65913C (fi) | 1982-04-07 | 1982-04-07 | Foerfarande foer framstaellning av jaern och selen innehaollande spaoraemnespreparat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS229183A2 CS229183A2 (en) | 1985-06-13 |
| CS240957B2 true CS240957B2 (en) | 1986-03-13 |
Family
ID=8515330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS832291A CS240957B2 (en) | 1982-04-07 | 1983-04-01 | Production method of stabile solution containing iron and selenium |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4476114A (da) |
| EP (1) | EP0091762B1 (da) |
| AU (1) | AU553154B2 (da) |
| CS (1) | CS240957B2 (da) |
| DD (1) | DD209611A5 (da) |
| DE (1) | DE3360380D1 (da) |
| DK (1) | DK156122C (da) |
| FI (1) | FI65913C (da) |
| HU (1) | HU188446B (da) |
| IE (1) | IE54475B1 (da) |
| PL (1) | PL138117B1 (da) |
| ZA (1) | ZA832045B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE440591B (sv) * | 1983-06-14 | 1985-08-12 | Cederroths Ab | Mineralsaltblandning innehallande selen |
| US5000957A (en) * | 1984-03-19 | 1991-03-19 | Alza Corporation | Dispenser comprising hydrophilic osmopolymer |
| US4927633A (en) * | 1984-03-19 | 1990-05-22 | Alza Corporation | Dispenser for delivering drug to livestock |
| SE500971C2 (sv) * | 1992-08-25 | 1994-10-10 | Kemira Kemi Ab | Användning av en sulfit- eller selenitjonproducerande substans för beredning av ett medel med skatolinhiberande verkan |
| US5639482A (en) * | 1993-11-10 | 1997-06-17 | Crary; Ely J. | Composition for control and prevention of diabetic retinopathy |
| RU2176916C1 (ru) * | 2001-01-22 | 2001-12-20 | Новицкий Юрий Алексеевич | Селеновое гликопротеиновое элементорганическое вещество, обладающее иммуностимулирующим действием (его варианты) |
| RU2242233C1 (ru) * | 2003-12-15 | 2004-12-20 | Новицкий Юрий Алексеевич | Наномолекулярное селенопротеиновое органическое вещество, обладающее активным иммунотропным и метаболическим действием |
| RU2242235C1 (ru) * | 2003-12-29 | 2004-12-20 | Новицкий Юрий Алексеевич | Наномолекулярное селенотерпенопротеиновое средство и способ лечения больных с зависимостью от психоактивных веществ |
| CN107519198A (zh) * | 2017-07-21 | 2017-12-29 | 南通市第人民医院 | 一种右旋糖酐铁注射液及其制备方法 |
| EP3578182A1 (en) * | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulations containing triazinones and iron with a low amount of free iron ions |
| CN109852648B (zh) * | 2019-04-11 | 2022-08-09 | 广西大学 | 酶法制备右旋糖酐硒聚物的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2820740A (en) * | 1953-02-27 | 1958-01-21 | Benger Lab Ltd | Therapeutic preparations of iron |
| US3022221A (en) * | 1959-04-16 | 1962-02-20 | Chemicals Inc | Iron hydrogenated dextran |
| US3076798A (en) * | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
| US3829566A (en) * | 1964-03-17 | 1974-08-13 | Chromalloy Pharma Inc | Method for control of white muscle disease |
| GB2090133A (en) * | 1980-11-12 | 1982-07-07 | Patterson Janice Anne | Veterinary Composition containing Vitamin E and Selenium Compounds |
-
1982
- 1982-04-07 FI FI821233A patent/FI65913C/fi not_active IP Right Cessation
-
1983
- 1983-03-23 ZA ZA832045A patent/ZA832045B/xx unknown
- 1983-03-24 AU AU12798/83A patent/AU553154B2/en not_active Ceased
- 1983-03-29 DK DK143683A patent/DK156122C/da not_active IP Right Cessation
- 1983-03-31 DE DE8383301863T patent/DE3360380D1/de not_active Expired
- 1983-03-31 EP EP83301863A patent/EP0091762B1/en not_active Expired
- 1983-04-01 CS CS832291A patent/CS240957B2/cs unknown
- 1983-04-05 US US06/482,263 patent/US4476114A/en not_active Expired - Fee Related
- 1983-04-06 PL PL1983241367A patent/PL138117B1/pl unknown
- 1983-04-07 HU HU831207A patent/HU188446B/hu not_active IP Right Cessation
- 1983-04-07 DD DD83249649A patent/DD209611A5/de not_active IP Right Cessation
- 1983-04-07 IE IE790/83A patent/IE54475B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI821233L (fi) | 1983-10-08 |
| CS229183A2 (en) | 1985-06-13 |
| DK143683A (da) | 1983-10-08 |
| DK156122C (da) | 1989-11-20 |
| HU188446B (en) | 1986-04-28 |
| DK156122B (da) | 1989-06-26 |
| FI821233A0 (fi) | 1982-04-07 |
| EP0091762B1 (en) | 1985-07-10 |
| PL138117B1 (en) | 1986-08-30 |
| AU1279883A (en) | 1983-10-13 |
| DK143683D0 (da) | 1983-03-29 |
| EP0091762A1 (en) | 1983-10-19 |
| DE3360380D1 (en) | 1985-08-14 |
| FI65913C (fi) | 1984-08-10 |
| IE54475B1 (en) | 1989-10-25 |
| DD209611A5 (de) | 1984-05-16 |
| PL241367A1 (en) | 1984-07-16 |
| IE830790L (en) | 1983-10-07 |
| US4476114A (en) | 1984-10-09 |
| AU553154B2 (en) | 1986-07-03 |
| ZA832045B (en) | 1983-12-28 |
| FI65913B (fi) | 1984-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI93309C (fi) | Menetelmä stabiilin sinkki-protamiini- -interferonikompleksin valmistamiseksi | |
| CA1039192A (en) | Composition and method for treating scours | |
| EP0444692A1 (en) | Thrombin composition for oral administration | |
| CS209458B2 (en) | Method of making the complex of the insuline salt with the protamine | |
| CS240957B2 (en) | Production method of stabile solution containing iron and selenium | |
| CA1302278C (en) | Injection solutions of torasemide which are ready to use and processes for their preparation thereof | |
| Read et al. | Studies with 15 N-labeled ammonia and urea in the malnourished child | |
| Garner et al. | Fission products and the dairy cow. 2. Some aspects of the metabolism of the alkaline-earth elements calcium, strontium and barium | |
| RU2130312C1 (ru) | Лечебный препарат, обладающий бактерицидным и вирулицидным действием - йодомидол | |
| CZ20011998A3 (cs) | Troferutin s vysokým obsahem trihydroxietylrutinu a způsob jeho výroby | |
| US3155587A (en) | Stable liquid preparations of 7-chlorotetracycline | |
| JPS635028A (ja) | 凍結乾燥医薬組成物 | |
| JPH0651628B2 (ja) | 栄養剤組成物 | |
| EP0038013B1 (en) | Injectable oxytetracycline compositions | |
| EP0013625B1 (en) | Solubilized thymidine composition and method of producing same | |
| JP2026501722A (ja) | 微量元素組成物、その調製方法およびその使用 | |
| Bowman | Growth hormone activity of the anterior pituitary lobe of the male rat at various ages | |
| Stanley et al. | Cobalt polycythemia. II. Relative effects of oral and subcutaneous administration of cobaltous chloride | |
| BILLS | HOLS, SINGLY AND IN ADMIXTURE, ON | |
| US2698819A (en) | Ethylenediamine tetraacetic acid periodides and compositions thereof | |
| Jacobsson | Excretion of a single dose of selenium in sheep | |
| US3065138A (en) | Therapeutic preparations of elemental iron | |
| US4399127A (en) | Injectable oxytetracycline compositions | |
| US4386083A (en) | Injectable oxytetracycline compositions | |
| Beavon et al. | The pH-dependent rearrangements of formyltetrahydrofolates and their nutritional implications |